Your institution may have access to this item. Find your institution then sign in to continue.
Title
Use of the 40-gene Expression Profile (40-GEP) Test in Medicareeligible Patients Diagnosed with Cutaneous Squamous Cell Carcinoma (cSCC) to Guide Adjuvant Radiation Therapy (ART) Decisions Leads to a Significant Reduction in Healthcare Costs.